Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Br J Dermatol
; 190(4): 549-558, 2024 Mar 15.
Article
in En
| MEDLINE
| ID: mdl-38006317
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Melanoma
/
Membrane Proteins
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Br J Dermatol
Year:
2024
Document type:
Article
Affiliation country:
Reino Unido